Clinical trial
Post-Marketing Surveillance of Fycompa in Korean Patients
NCT02722590 is registered in ClinicalTrials.gov with Eisai Korea Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Post-Marketing Surveillance of Fycompa in Korean Patients
- Lead sponsor
- Eisai Korea Inc.
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 1, 2016
- Completion date
- June 30, 2021
- Enrollment
- 3,692 (actual)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.